FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Fay

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Physiology

Co-author Network

Publications

TOP 3
A P Owens; H C Whinna; William P Fay; C Gachet; Y Lu; N Mackman
Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model.
Mozow Y Zuidema; Kelly J Peyton; William Durante; William P Fay; Ronald J Korthuis
Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1.
Arun Kumar; Subrata Kar; William P Fay
Thrombosis, physical activity, and acute coronary syndromes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Fay (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: A P Owens; H C Whinna; William P Fay; C Gachet; Y Lu; N Mackman
Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model.
Journal of thrombosis and haemostasis : JTH 2011;9(9):1862-3.
2011: Mozow Y Zuidema; Kelly J Peyton; William Durante; William P Fay; Ronald J Korthuis
Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1.
American journal of physiology. Heart and circulatory physiology 2011;301(3):H888-94.
2011: Arun Kumar; Subrata Kar; William P Fay
Thrombosis, physical activity, and acute coronary syndromes.
Journal of applied physiology (Bethesda, Md. : 1985) 2011;111(2):599-605.
2010: William P Fay
Linking inflammation and thrombosis: Role of C-reactive protein.
World journal of cardiology 2010;2(11):365-9.
2010: N Garg; N Goyal; T L Strawn; J Wu; K M Mann; Daniel Lawrence; William P Fay
Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices.
Journal of thrombosis and haemostasis : JTH 2010;8(8):1847-54.
2009: Jianbo Wu; Lin Peng; Grainne A McMahon; Daniel Lawrence; William P Fay
Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(10):1565-70.
2008: Jianbo Wu; Meredith J Stevenson; Jordan M Brown; Elizabeth A Grunz; Tammy L Strawn; William P Fay
C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(4):698-704.
2007: Nadish Garg; William P Fay
Plasminogen activator inhibitor-1 and restenosis.
Current drug targets 2007;8(9):1003-6.
2007: William P Fay; Nadish Garg; Madhavi Sunkar
Vascular functions of the plasminogen activation system.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(6):1231-7.
2007: Jacob P Deerhake; Julie C Merz; Jeanna V Cooper; Kim A Eagle; William P Fay
The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
Journal of thrombosis and thrombolysis 2007;23(2):107-13.
2006: Rachel E Tilley; Brian Pedersen; Rafal Pawlinski; Yuichiro Sato; Jonathan Erlich; Yuechun Shen; Sharlene M Day; Ying Huang; Daniel T Eitzman; William A Boisvert; Linda K Curtiss; William P Fay; Nigel Mackman
Atherosclerosis in mice is not affected by a reduction in tissue factor expression.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(3):555-62.
2005: Sergey Filippov; Gerald C Koenig; Tae-Hwa Chun; Kevin B Hotary; Ichiro Ota; Thomas H Bugge; Joseph D Roberts; William P Fay; Henning Birkedal-Hansen; Kenn Holmbeck; Farideh Sabeh; Edward D Allen; Stephen J Weiss
MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells.
The Journal of experimental medicine 2005;202(5):663-71.
2005: Sharlene M Day; Jennifer L Reeve; Brian Pedersen; Diana M Farris; Daniel Durant Myers Jr; Michael Im; Thomas W Wakefield; Nigel Mackman; William P Fay
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall.
Blood 2005;105(1):192-8.
2004: Andrew C Parker; Lakshmi V Mundada; Alvin H Schmaier; William P Fay
Factor VLeiden inhibits fibrinolysis in vivo.
Circulation 2004;110(23):3594-8.
2004: Sharlene M Day; Jennifer L Reeve; Daniel Durant Myers Jr; William P Fay
Murine thrombosis models.
Thrombosis and haemostasis 2004;92(3):486-94.
2004: Hongmin Sun; Ulrika Ringdahl; Jonathon W Homeister; William P Fay; N Cary Engleberg; Angela Y Yang; Laura S Rozek; Xixi Wang; Ulf Sjöbring; David Ginsburg
Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.
Science (New York, N.Y.) 2004;305(5688):1283-6.
2004: Lin Peng; Lakshmi V Mundada; Joshua M Stomel; Jason J Liu; Jinhong Sun; Shaw-Fang Yet; William P Fay
Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis.
Antioxidants & redox signaling 2004;6(4):729-35.
2004: William P Fay
Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury.
Trends in cardiovascular medicine 2004;14(5):196-202.
2003: Jinmo Khil; Michael Im; Andrew Heath; Ulrika Ringdahl; Lakshmi V Mundada; N Cary Engleberg; William P Fay
Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms.
The Journal of infectious diseases 2003;188(4):497-505.
2003: Lakshmi V Mundada; Zhenyu Sheng; Melanie E DeFord; Mariana Figuera; Francis J Castellino; William P Fay
Structure-function analysis of the streptokinase amino terminus (residues 1-59).
The Journal of biological chemistry 2003;278(27):24421-7.
2003: Sharlene M Day; Damon Duquaine; Lakshmi V Mundada; Rekha G Menon; Bobby V Khan; Sanjay Rajagopalan; William P Fay
Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis.
Circulation 2003;107(20):2601-6.
2003: Hakan Oral; Natarajan Sivasubramanian; David B Dyke; Rajendra H Mehta; P Michael Grossman; Kerri Briesmiester; William P Fay; Francis D Pagani; Steven F Bolling; Douglas L Mann; Mark R Starling
Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation.
Circulation 2003;107(6):831-7.
2002: Sheila Chuang; Rajendra H Mehta; William P Fay
Prolonged low-dose thrombolytic therapy: a novel adjunctive strategy in the management of an infected right atrial thrombus.
Clinical cardiology 2002;25(7):346-9.
2002: Lin Peng; Nitin Bhatia; Andrew C Parker; Yanhong Zhu; William P Fay
Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(6):934-9.
2002: Yanhong Zhu; Richard Tomasiak; William P Fay
Do clinically relevant circulating concentrations of radiographic contrast agents inhibit platelet-dependent arterial thrombosis?
Thrombosis research 2002;105(5):413-8.
2001: Peter M Farrehi; Yanhong Zhu; William P Fay
An analysis of mechanisms underlying the antifibrinolytic properties of radiographic contrast agents.
Journal of thrombosis and thrombolysis 2001;12(3):273-81.
2001: Yanhong Zhu; Peter M Farrehi; William P Fay
Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Circulation 2001;103(25):3105-10.
1999: Yanhong Zhu; P Carmeliet; William P Fay
Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
Circulation 1999;99(23):3050-5.
1999: William P Fay; Andrew C Parker; M N Ansari; X Zheng; David Ginsburg
Vitronectin inhibits the thrombotic response to arterial injury in mice.
Blood 1999;93(6):1825-30.
1999: Hakan Oral; Susan G Fisher; William P Fay; Steven N Singh; Ross D Fletcher; Fred Morady
Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
The American journal of cardiology 1999;83(3):388-91.
1998: Claire S Duvernoy; Eric R Bates; William P Fay; Peter M Farrehi; Steven W Werns
Acute myocardial infarction in two adolescent males.
Clinical cardiology 1998;21(9):687-90.
1998: William P Fay; Andrew C Parker
Effects of radiographic contrast agents on thrombin formation and activity.
Thrombosis and haemostasis 1998;80(2):266-72.
1998: William P Fay; L V Bokka
Functional analysis of the amino- and carboxyl-termini of streptokinase.
Thrombosis and haemostasis 1998;79(5):985-91.
1998: Peter M Farrehi; C Keith Ozaki; P Carmeliet; William P Fay
Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice.
Circulation 1998;97(10):1002-8.
1997: William P Fay; Andrew C Parker; L R Condrey; Amy D Shapiro
Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene.
Blood 1997;90(1):204-8.
1996: William P Fay; J G Murphy; Whyte G Owen
High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(10):1277-84.
1996: Daniel T Eitzman; R D McCoy; X Zheng; William P Fay; T Shen; David Ginsburg; Richard H Simon
Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.
The Journal of clinical investigation 1996;97(1):232-7.
1995: Daniel T Eitzman; William P Fay; Daniel Lawrence; A M Francis-Chmura; Joseph D Shore; Steven T Olson; David Ginsburg
Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.
The Journal of clinical investigation 1995;95(5):2416-20.
1995: G Reis; P A Marcovitz; Alan B Leichtman; Robert M Merion; William P Fay; Steven W Werns; William F Armstrong
Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease.
The American journal of cardiology 1995;75(10):707-10.
1994: Daniel T Eitzman; L Chi; L Saggin; R S Schwartz; Benedict R Lucchesi; William P Fay
Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4.
Circulation 1994;89(4):1523-9.
1994: William P Fay; Daniel T Eitzman; Amy D Shapiro; E L Madison; David Ginsburg
Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.
Blood 1994;83(2):351-6.
1992: William P Fay; Amy D Shapiro; J L Shih; R R Schleef; David Ginsburg
Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation.
The New England journal of medicine 1992;327(24):1729-33.
1989: William P Fay; Whyte G Owen
Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.
Biochemistry 1989;28(14):5773-8.